Abstract:Purpose
Neoadjuvant chemotherapy (NAC) for triple negative (TN) and Her2 positive (HER2) breast cancers is supported by international guidelines as it can decrease extent of surgery, provide prognostic information and allow response-driven adjuvant therapies. Our goal was to describe practice patterns for patients with TN and HER2 breast cancer and identify factors associated with the receipt of NAC versus surgery as initial treatment.
Methods
A retrospective population-based cohort study of adult women diagn… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.